Literature DB >> 22517423

Regulation and function of mTOR signalling in T cell fate decisions.

Hongbo Chi1.   

Abstract

The evolutionarily conserved kinase mTOR (mammalian target of rapamycin) couples cell growth and metabolism to environmental inputs in eukaryotes. T cells depend on mTOR signalling to integrate immune signals and metabolic cues for their proper maintenance and activation. Under steady-state conditions, mTOR is actively controlled by multiple inhibitory mechanisms, and this enforces normal T cell homeostasis. Antigen recognition by naive CD4(+) and CD8(+) T cells triggers mTOR activation, which in turn programmes the differentiation of these cells into functionally distinct lineages. This Review focuses on the signalling mechanisms of mTOR in T cell homeostatic and functional fates, and discusses the therapeutic implications of targeting mTOR in T cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517423      PMCID: PMC3417069          DOI: 10.1038/nri3198

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  154 in total

1.  OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.

Authors:  Takanori So; Heonsik Choi; Michael Croft
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

Review 2.  Apoptosis and autophagy in the regulation of T lymphocyte function.

Authors:  Alexis Dunkle; You-Wen He
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

3.  The Lkb1 metabolic sensor maintains haematopoietic stem cell survival.

Authors:  Sushma Gurumurthy; Stephanie Z Xie; Brinda Alagesan; Judith Kim; Rushdia Z Yusuf; Borja Saez; Alexandros Tzatsos; Fatih Ozsolak; Patrice Milos; Francesco Ferrari; Peter J Park; Orian S Shirihai; David T Scadden; Nabeel Bardeesy
Journal:  Nature       Date:  2010-12-02       Impact factor: 49.962

4.  IL-7 enhances the survival and maintains the size of naive T cells.

Authors:  J C Rathmell; E A Farkash; W Gao; C B Thompson
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

5.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

6.  Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.

Authors:  Andrew Y Choo; Sang Gyun Kim; Matthew G Vander Heiden; Sarah J Mahoney; Hieu Vu; Sang-Oh Yoon; Lewis C Cantley; John Blenis
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

Review 7.  Immunoregulatory functions of mTOR inhibition.

Authors:  Angus W Thomson; Hēth R Turnquist; Giorgio Raimondi
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

8.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

9.  A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection.

Authors:  Michael Quigley; Jennifer Martinez; Xiaopei Huang; Yiping Yang
Journal:  Blood       Date:  2008-10-23       Impact factor: 22.113

Review 10.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

View more
  367 in total

Review 1.  Molecular regulation of effector and memory T cell differentiation.

Authors:  John T Chang; E John Wherry; Ananda W Goldrath
Journal:  Nat Immunol       Date:  2014-12       Impact factor: 25.606

2.  The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated Inflammation.

Authors:  Wook-Jin Chae; Allison K Ehrlich; Pamela Y Chan; Alexandra M Teixeira; Octavian Henegariu; Liming Hao; Jae Hun Shin; Jong-Hyun Park; Wai Ho Tang; Sang-Taek Kim; Stephen E Maher; Karen Goldsmith-Pestana; Peiying Shan; John Hwa; Patty J Lee; Diane S Krause; Carla V Rothlin; Diane McMahon-Pratt; Alfred L M Bothwell
Journal:  Immunity       Date:  2016-02-09       Impact factor: 31.745

3.  The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway.

Authors:  Zhenke Wen; Yi Shen; Gerald Berry; Farhad Shahram; Yinyin Li; Ryu Watanabe; Yaping Joyce Liao; Jörg J Goronzy; Cornelia M Weyand
Journal:  Sci Transl Med       Date:  2017-07-19       Impact factor: 17.956

Review 4.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 5.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

6.  Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells.

Authors:  Yanyan Wang; Gonghua Huang; Hu Zeng; Kai Yang; Richard F Lamb; Hongbo Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

7.  Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.

Authors:  Zhi-Wei Lai; Ryan Kelly; Thomas Winans; Ivan Marchena; Ashwini Shadakshari; Julie Yu; Maha Dawood; Ricardo Garcia; Hajra Tily; Lisa Francis; Stephen V Faraone; Paul E Phillips; Andras Perl
Journal:  Lancet       Date:  2018-03-15       Impact factor: 79.321

8.  Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation.

Authors:  Hung D Nguyen; Shilpak Chatterjee; Kelley M K Haarberg; Yongxia Wu; David Bastian; Jessica Heinrichs; Jianing Fu; Anusara Daenthanasanmak; Steven Schutt; Sharad Shrestha; Chen Liu; Honglin Wang; Hongbo Chi; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

Review 9.  The obesity-related pathology and Th17 cells.

Authors:  Yusuke Endo; Koutaro Yokote; Toshinori Nakayama
Journal:  Cell Mol Life Sci       Date:  2016-10-18       Impact factor: 9.261

10.  mTOR signaling and transcriptional regulation in T lymphocytes.

Authors:  Hu Zeng; Hongbo Chi
Journal:  Transcription       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.